Genocea Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Genocea Biosciences

29/07/2021 14:32

* Genocea Biosciences Inc  GNCA.OQ  reported a quarterly
adjusted loss of 20 cents​​ per share for the quarter ended in
June. The mean expectation of five analysts for the quarter was
for a loss of 18 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* The mean earnings estimate of analysts had risen by about 4.2%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Genocea Biosciences Inc shares had fallen by 13.2% this
quarter and lost 16.1% so far this year.
* The company reported a quarterly loss of $4.31 million.
* Wall Street's median 12-month price target for Genocea
Biosciences Inc is $6.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated July 29 at 01:32 p.m.  ​All
figures in US dollars unless otherwise stated